Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey

Sanisoğlu, S. Yavuz; Öktenli, Çağatay; Haşimi, Adnan; Yokuşoğlu, Mehmet; Uğurlu, Mehmet

doi:10.1186/1471-2458-6-92

Cited by 88 publications

(70 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among the subjects with MS, the prevalence of high blood pressure and hyperglycemia were higher in Turkey than in the USA. In contrast, the prevalence of abdominal obesity, low HDL and hypertriglyceridemia were lower in our population compared with population of the USA (Sanisoglu et al, 2006). Prevalence of other components of MS in Turkish population and US subjects was not much different.…”

Section: Components Of Mscontrasting

confidence: 72%

“…Similar to our results, they reported the prevalence of the MS was 33.4% and was more common in women than in men (39.1 vs 23.7). Sanisoglu et al (2006) recently reported a prevalence of 27.38% for MS that is apparently low for our country. However, their study was designed to investigate the nutrition status of the population, not the prevalence of MS.…”

Section: Discussionmentioning

confidence: 65%

See 1 more Smart Citation

Prevalence of the metabolic syndrome among Turkish adults

Oğuz²,

et al. 2006

View full text Add to dashboard Cite

Objective: To determine prevalence of the metabolic syndrome (MS) in a sample representing Turkish population using United States Adult Treatment Panel-3 guidelines. Design: The study included random samples from both urban and rural populations in the seven geographical regions of Turkey. The population for this analysis were 2108 men (1372 in urban and 736 in rural areas) and 2151 women (1423 in urban and 728 in rural areas) with a mean age of 40.9714.9 years (range 20-90). Results: The prevalence of the MS diagnosed using the Adult Treatment Panel III criteria was 33.9% (1442 of 4259) and differed significantly in men (28%) and women (39.6%). The prevalence of syndrome increased with age in men, from 10.7% in subjects aged 20-29 years to 49% in those aged over 70 years. The prevalence increased with age in women, from 9.6% in subjects aged 20-29 years to 74.6% in those aged 60-69 years, and decreased to 68.6% in those over 70 years of age. The prevalence of the syndrome was similar in urban (33.8%) and rural (33.9%) population. We found 26.8, 26.4, 19.3, 10.9 and 3.6% of the population had at least 1, 2, 3, 4 or 5 components, respectively. We found 57.2, 32.3 and 10.6% of the subjects with MS had 3, 4 and 5 components, respectively.

show abstract

Section: Components Of Mscontrasting

confidence: 72%

Section: Discussionmentioning

confidence: 65%

Prevalence of the metabolic syndrome among Turkish adults

Oğuz²,

et al. 2006

View full text Add to dashboard Cite

show abstract

“…Incidence of metabolic syndrome increases as age progresses. In a study in Turkey, the prevalence of the metabolic syndrome was 15.3%, 23.1%, 28.0%, 26.0%, and 20.5% among people aged from 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79 and ≥ 80 years old, respectively [17]. Study in Norway showed that prevalence of the metabolic syndrome elevated with age into the ninth decade of life [18].…”

Section: Introductionmentioning

confidence: 98%

A Review on Metabolic Syndrome

Marjani

2012

J Endocrinol Metab

View full text Add to dashboard Cite

The metabolic syndrome is described by the clustering of several risk factors for Type 2 diabetes and cardiovascular disease. Lipid disorder, obesity, diabetes in general and high blood pressure are collectively defined as risk factors for cardiovascular disease triggered by metabolic syndrome. The metabolic syndromes have a correlation with the variations in genetic susceptibility, nutritional regiment, physical exercise, chronological age and gender which play direct role in the incidence of metabolic syndrome and its side effects. There are several definitions of Metabolic Syndrome in the World: World Health Organization's (WHO), The NCEP Adult Treatment Panel (ATP) III and the International Diabetes Federation (IDF). It appears that the female type 2 diabetic patients need to change their life style to halt the burden of cardiovascular complications in type 2 diabetic patients. Clinicians should significantly consider screening all people regardless of age for abnormalities in glucose level. Early treatment in people with abnormal glucose level constitutes a strategy of preventing type 2 diabetes mellitus and metabolic syndrome. Studies about metabolic syndrome have shown that females were more affected than males. This may be due to the specific characteristics in the lifestyle changes between females and males diabetic patients. Postmenopausal status might be a predictor of metabolic syndrome. Some related factors of metabolic syndrome among postmenopausal women may increase cardiovascular risk in postmenopausal women.

show abstract

“…Its incidence and prevalence have risen dramatically, especially in the western countries, as a result of the increasing prevalence of obesity [5]. As in schizophrenia, there is great concern about the prevalence of metabolic syndrome in patients with bipolar disorder, although research in this area is scarce [6]. Study by Fagiolini et al [7] of 171 subjects revealed a prevalence of metabolic syndrome in bipolar disorders as high as 30% compared to the general population.…”

Section: Introductionmentioning

confidence: 99%

“…There is a statistically significant association between atypical antipsychotics and metabolic syndrome. However, there are no such association between mood stabilizers and metabolic syndrome [6]. This study evaluates the prevalence of metabolic syndrome in 32 patients with bipolar disorder that are either on Li or VPA monotherapy.…”

Section: Introductionmentioning

confidence: 99%